Home › Comparisons › Hedera vs. AbbVie
Hedera vs. AbbVie: €1,000 since 21/11/2023
Hedera (HBAR)
€950.26
-5.0 % since start
AbbVie (ABBV)
€2,268
+126.8 % since start
Largest drop
-86.0 %
Hedera · AbbVie: -26.5 %
What this means
Had you invested €1,000 in Hedera on 21/11/2023, it would have grown to €950.26 by 18/11/2026 (-5.0 %). The same amount in AbbVie would give €2,268 (+126.8 %). Over this period (3.0 years), AbbVie came out ahead. The largest interim drop was -86.0 % for Hedera and -26.5 % for AbbVie. Annual volatility was 99.8 % and 25.0 % respectively.
Popular comparisons
Not investment advice. Past performance is not a reliable indicator of future results. Past performance says nothing about future results. This is an automatically generated analysis of public price data, not advice to buy or sell.